speb/financial-data huggingface dataset:
IQST cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 8815.00
IQST income_statement (annual, 2023-12-31) — Basic Average Shares: 2127187.00
IQST income_statement (annual, 2023-12-31) — Basic EPS: -0.79
IQST cash_flow (annual, 2023-12-31) — Beginning Cash Position: 1329389.00
IQST cash_flow (annual, 2023-12-31) — Capital Expenditure: -220045.00
IQST balance_sheet (annual, 2023-12-31) — Capital Stock: 172171.00
IQST balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 1362668.00
IQST balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 1362668.00
IQST balance_sheet (annual, 2023-12-31) — Cash Financial: 1362668.00
IQST cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 1833965.00
IQST cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -332550.00
IQST cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -1483801.00
IQST cash_flow (annual, 2023-12-31) — Change In Account Payable: 1217926.00
IQST cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 6623327.00
IQST cash_flow (annual, 2023-12-31) — Change In Inventory: -997.00
IQST cash_flow (annual, 2023-12-31) — Change In Payable: 1217926.00
IQST cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 7841253.00
IQST cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -1085279.00
IQST cash_flow (annual, 2023-12-31) — Change In Receivables: -7917462.00
IQST cash_flow (annual, 2023-12-31) — Change In Working Capital: -1162485.00
IQST cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -8010726.00
IQST cash_flow (annual, 2023-12-31) — Changes In Cash: 17614.00
IQST balance_sheet (annual, 2023-12-31) — Common Stock: 172130.00
IQST balance_sheet (annual, 2023-12-31) — Common Stock Equity: 8423541.00
IQST cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
IQST income_statement (annual, 2023-12-31) — Cost Of Revenue: 139830338.00
IQST balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 45360.00
IQST balance_sheet (annual, 2023-12-31) — Current Assets: 15719172.00
IQST balance_sheet (annual, 2023-12-31) — Current Debt: 854467.00
IQST balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 854467.00
IQST balance_sheet (annual, 2023-12-31) — Current Liabilities: 13840944.00
IQST balance_sheet (annual, 2023-12-31) — Current Provisions: 9613332.00
IQST cash_flow (annual, 2023-12-31) — Deferred Income Tax: 53568.00
IQST cash_flow (annual, 2023-12-31) — Deferred Tax: 53568.00
IQST cash_flow (annual, 2023-12-31) — Depreciation: 128737.00
IQST cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 128737.00
IQST income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 128737.00
IQST cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 128737.00
IQST income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 128737.00
IQST income_statement (annual, 2023-12-31) — Diluted Average Shares: 2127187.00
IQST income_statement (annual, 2023-12-31) — Diluted EPS: -0.79
IQST income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -1579738.00
IQST balance_sheet (annual, 2023-12-31) — Duefrom Related Parties Current: 340515.00
IQST balance_sheet (annual, 2023-12-31) — Dueto Related Parties Current: 26613.00
IQST income_statement (annual, 2023-12-31) — EBIT: -124528.00
IQST income_statement (annual, 2023-12-31) — EBITDA: 4209.00
IQST cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 15665.00
IQST balance_sheet (annual, 2023-12-31) — Employee Benefits: 169738.00
IQST cash_flow (annual, 2023-12-31) — End Cash Position: 1362668.00
IQST cash_flow (annual, 2023-12-31) — Financing Cash Flow: 1833965.00
IQST cash_flow (annual, 2023-12-31) — Free Cash Flow: -1703846.00
IQST cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -381848.00
IQST income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 381848.00
IQST balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -25340.00
IQST income_statement (annual, 2023-12-31) — General And Administrative Expense: 3965544.00
IQST balance_sheet (annual, 2023-12-31) — Goodwill: 5172146.00
IQST balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 5271738.00
IQST balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 12548589.00
IQST balance_sheet (annual, 2023-12-31) — Gross PPE: 1323432.00
IQST income_statement (annual, 2023-12-31) — Gross Profit: 4672013.00
IQST cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 0.00
IQST income_statement (annual, 2023-12-31) — Insurance And Claims: 11914.00
IQST income_statement (annual, 2023-12-31) — Interest Expense: 94908.00
IQST income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 94908.00
IQST cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 45282.00
IQST balance_sheet (annual, 2023-12-31) — Interest Payable: 17318.00
IQST balance_sheet (annual, 2023-12-31) — Inventory: 27121.00
IQST balance_sheet (annual, 2023-12-31) — Invested Capital: 9377107.00
IQST cash_flow (annual, 2023-12-31) — Investing Cash Flow: -332550.00
IQST cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
IQST cash_flow (annual, 2023-12-31) — Issuance Of Debt: 625000.00
IQST balance_sheet (annual, 2023-12-31) — Long Term Debt: 99099.00
IQST balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 99099.00
IQST cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 375000.00
IQST cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -18559.00
IQST balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 836840.00
IQST balance_sheet (annual, 2023-12-31) — Minority Interest: -377710.00
IQST income_statement (annual, 2023-12-31) — Minority Interests: -543822.00
IQST cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
IQST cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
IQST income_statement (annual, 2023-12-31) — Net Income: -763258.00
IQST income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -1579738.00
IQST income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -219436.00
IQST income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -763258.00
IQST income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -763258.00
IQST cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -219436.00
IQST income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -219436.00
IQST income_statement (annual, 2023-12-31) — Net Interest Income: -172200.00
IQST cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 433965.00
IQST cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 356441.00
IQST income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -172200.00
IQST cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -112505.00
IQST balance_sheet (annual, 2023-12-31) — Net PPE: 522997.00
IQST cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -220045.00
IQST cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 77524.00
IQST balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 3151844.00
IQST balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 426755.00
IQST balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 426755.00
IQST income_statement (annual, 2023-12-31) — Normalized EBITDA: -368824.00
IQST income_statement (annual, 2023-12-31) — Normalized Income: -1136291.00
IQST cash_flow (annual, 2023-12-31) — Operating Cash Flow: -1483801.00
IQST cash_flow (annual, 2023-12-31) — Operating Gains Losses: -374648.00
IQST income_statement (annual, 2023-12-31) — Operating Income: -229396.00
IQST income_statement (annual, 2023-12-31) — Operating Revenue: 144502351.00
IQST balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 2188843.00
IQST balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 854467.00
IQST balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 121020.00
IQST balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -25340.00
IQST income_statement (annual, 2023-12-31) — Other Gand A: 2350374.00
IQST income_statement (annual, 2023-12-31) — Other Income Expense: 182160.00
IQST balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 99592.00
IQST cash_flow (annual, 2023-12-31) — Other Non Cash Items: 38758.00
IQST balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 214991.00
IQST income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -190873.00
IQST balance_sheet (annual, 2023-12-31) — Other Payable: 213873.00
IQST balance_sheet (annual, 2023-12-31) — Other Properties: 486592.00
IQST balance_sheet (annual, 2023-12-31) — Other Receivables: 312116.00
IQST balance_sheet (annual, 2023-12-31) — Payables: 3206765.00
IQST balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 3252125.00
IQST balance_sheet (annual, 2023-12-31) — Preferred Stock: 41.00
IQST income_statement (annual, 2023-12-31) — Preferred Stock Dividends: 816480.00
IQST balance_sheet (annual, 2023-12-31) — Preferred Stock Equity: 41.00
IQST balance_sheet (annual, 2023-12-31) — Prepaid Assets: 1136550.00
IQST income_statement (annual, 2023-12-31) — Pretax Income: -219436.00
IQST cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 1400000.00
IQST cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
IQST cash_flow (annual, 2023-12-31) — Purchase Of PPE: -220045.00
IQST balance_sheet (annual, 2023-12-31) — Receivables: 13192833.00
IQST income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 139830338.00
IQST income_statement (annual, 2023-12-31) — Reconciled Depreciation: 128737.00
IQST cash_flow (annual, 2023-12-31) — Repayment Of Debt: -191035.00
IQST balance_sheet (annual, 2023-12-31) — Retained Earnings: -26084133.00
IQST income_statement (annual, 2023-12-31) — Salaries And Wages: 1603256.00
IQST income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 807128.00
IQST income_statement (annual, 2023-12-31) — Selling General And Administration: 4772672.00
IQST balance_sheet (annual, 2023-12-31) — Share Issued: 2188843.00
IQST cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 250000.00
IQST cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -172476.00
IQST income_statement (annual, 2023-12-31) — Special Income Charges: -8815.00
IQST cash_flow (annual, 2023-12-31) — Stock Based Compensation: 42890.00
IQST balance_sheet (annual, 2023-12-31) — Stockholders Equity: 8423582.00
IQST balance_sheet (annual, 2023-12-31) — Tangible Book Value: 3151803.00
IQST income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
IQST income_statement (annual, 2023-12-31) — Tax Provision: 0.00
IQST income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
IQST balance_sheet (annual, 2023-12-31) — Taxes Receivable: 428.00
IQST balance_sheet (annual, 2023-12-31) — Total Assets: 22155653.00
IQST balance_sheet (annual, 2023-12-31) — Total Capitalization: 8522681.00
IQST balance_sheet (annual, 2023-12-31) — Total Debt: 953566.00
IQST balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 8045872.00
IQST income_statement (annual, 2023-12-31) — Total Expenses: 144731747.00
IQST balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 14109781.00
IQST balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 6436481.00
IQST balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 268837.00
IQST income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -315503.00
IQST income_statement (annual, 2023-12-31) — Total Other Finance Cost: 77292.00
IQST income_statement (annual, 2023-12-31) — Total Unusual Items: 373033.00
IQST income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 373033.00
IQST balance_sheet (annual, 2023-12-31) — Working Capital: 1878228.00
IQST income_statement (annual, 2023-12-31) — Write Off: 8815.00
IQST income_statement (quarterly, 2024-09-30) — Basic Average Shares: 2343408.00
IQST income_statement (quarterly, 2024-09-30) — Basic EPS: -0.39
IQST income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 2343408.00
IQST income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.39
IQST cash_flow (quarterly, 2024-09-30) — Effect Of Exchange Rate Changes: 0.00
IQST cash_flow (quarterly, 2024-09-30) — Gain Loss On Investment Securities: -51721.00
IQST income_statement (quarterly, 2024-09-30) — Gain On Sale Of Security: 51721.00
IQST cash_flow (quarterly, 2024-09-30) — Net Short Term Debt Issuance: 0.00
IQST cash_flow (quarterly, 2024-09-30) — Operating Gains Losses: -24184.00
IQST balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 1277946.00
IQST income_statement (quarterly, 2024-09-30) — Other Special Charges: 27537.00
IQST cash_flow (quarterly, 2024-09-30) — Proceeds From Stock Option Exercised: 175000.00
IQST cash_flow (quarterly, 2024-09-30) — Short Term Debt Payments: 0.00
IQST income_statement (annual, 2024-12-31) — +Operating Expense: 8892231.00
IQST income_statement (annual, 2024-12-31) — +Total Revenue: 283220442.00
IQST balance_sheet (annual, 2024-12-31) — Accounts Payable: 2129241.00
IQST balance_sheet (annual, 2024-12-31) — Accounts Receivable: 57158967.00
IQST balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -994292.00
IQST balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 39943924.00
IQST balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -1991.00
IQST balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -1991.00
IQST cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 360938.00
IQST cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 360938.00
IQST cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 1991.00
IQST income_statement (annual, 2024-12-31) — Basic Average Shares: 2314413.00
IQST income_statement (annual, 2024-12-31) — Basic EPS: -2.86
IQST cash_flow (annual, 2024-12-31) — Beginning Cash Position: 1362668.00
IQST cash_flow (annual, 2024-12-31) — Capital Expenditure: -151620.00
IQST balance_sheet (annual, 2024-12-31) — Capital Stock: 2583.00
IQST balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 2510357.00
IQST balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 2510357.00
IQST balance_sheet (annual, 2024-12-31) — Cash Financial: 2510357.00
IQST cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 7240966.00
IQST cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -3162971.00
IQST cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -2930306.00
IQST cash_flow (annual, 2024-12-31) — Change In Account Payable: 4448542.00
IQST cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 51315880.00
IQST cash_flow (annual, 2024-12-31) — Change In Inventory: -3537.00
IQST cash_flow (quarterly, 2024-12-31) — Change In Inventory: 0.00
IQST cash_flow (annual, 2024-12-31) — Change In Payable: 4448542.00
IQST cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 55764422.00
IQST cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -1235127.00
IQST cash_flow (annual, 2024-12-31) — Change In Receivables: -56111437.00
IQST cash_flow (annual, 2024-12-31) — Change In Working Capital: -1585679.00
IQST cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -56091437.00
IQST cash_flow (annual, 2024-12-31) — Changes In Cash: 1147689.00
IQST balance_sheet (annual, 2024-12-31) — Common Stock: 2537.00
IQST balance_sheet (annual, 2024-12-31) — Common Stock Equity: 7217711.00
IQST cash_flow (annual, 2024-12-31) — Common Stock Issuance: 200000.00
IQST cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 100000.00
IQST income_statement (annual, 2024-12-31) — Cost Of Revenue: 274948693.00
IQST balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 1047062.00
IQST balance_sheet (annual, 2024-12-31) — Current Assets: 63015046.00
IQST balance_sheet (annual, 2024-12-31) — Current Debt: 5040558.00
IQST balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 5040558.00
IQST balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 0.00
IQST balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 0.00
IQST balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 0.00
IQST balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 0.00
IQST balance_sheet (annual, 2024-12-31) — Current Liabilities: 63821196.00
IQST balance_sheet (annual, 2024-12-31) — Current Provisions: 53939336.00
IQST balance_sheet (quarterly, 2024-12-31) — Current Provisions: 53939336.00
IQST cash_flow (annual, 2024-12-31) — Deferred Income Tax: 138808.00
IQST cash_flow (annual, 2024-12-31) — Deferred Tax: 138808.00
IQST cash_flow (annual, 2024-12-31) — Depreciation: 138597.00
IQST cash_flow (quarterly, 2024-12-31) — Depreciation: 395474.00
IQST cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 499535.00
IQST income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 499535.00
IQST cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 499535.00
IQST income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 499535.00
IQST income_statement (annual, 2024-12-31) — Diluted Average Shares: 2314413.00
IQST income_statement (annual, 2024-12-31) — Diluted EPS: -2.86
IQST income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -6619277.00
IQST balance_sheet (annual, 2024-12-31) — Duefrom Related Parties Current: 630715.00
IQST balance_sheet (annual, 2024-12-31) — Dueto Related Parties Current: 26613.00
IQST income_statement (annual, 2024-12-31) — EBIT: -2626581.00
IQST income_statement (annual, 2024-12-31) — EBITDA: -2127046.00
IQST cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 0.00
IQST cash_flow (quarterly, 2024-12-31) — Effect Of Exchange Rate Changes: 0.00
IQST balance_sheet (annual, 2024-12-31) — Employee Benefits: 274353.00
IQST cash_flow (annual, 2024-12-31) — End Cash Position: 2510357.00
IQST cash_flow (annual, 2024-12-31) — Financing Cash Flow: 7240966.00
IQST cash_flow (annual, 2024-12-31) — Free Cash Flow: -3081926.00
IQST cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 1393046.00
IQST cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: 329257.00
IQST income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -1393046.00
IQST income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: -329257.00
IQST balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -25340.00
IQST income_statement (annual, 2024-12-31) — General And Administrative Expense: 6748885.00
IQST balance_sheet (annual, 2024-12-31) — Goodwill: 6750045.00
IQST balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 14188699.00
IQST balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 57160958.00
IQST balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 57160958.00
IQST balance_sheet (annual, 2024-12-31) — Gross PPE: 1556094.00
IQST income_statement (annual, 2024-12-31) — Gross Profit: 8271749.00
IQST income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
IQST cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 0.00
IQST cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 0.00
IQST income_statement (annual, 2024-12-31) — Insurance And Claims: 63534.00
IQST income_statement (annual, 2024-12-31) — Interest Expense: 2159425.00
IQST income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 2159425.00
IQST cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 879783.00
IQST balance_sheet (annual, 2024-12-31) — Interest Payable: 118204.00
IQST balance_sheet (quarterly, 2024-12-31) — Interest Payable: 118204.00
IQST balance_sheet (annual, 2024-12-31) — Inventory: 30658.00
IQST balance_sheet (annual, 2024-12-31) — Invested Capital: 15270195.00
IQST cash_flow (annual, 2024-12-31) — Investing Cash Flow: -3162971.00
IQST cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 200000.00
IQST cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 100000.00
IQST cash_flow (annual, 2024-12-31) — Issuance Of Debt: 9107351.00
IQST balance_sheet (annual, 2024-12-31) — Long Term Debt: 3011926.00
IQST balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 3011926.00
IQST balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 3011926.00
IQST balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 3011926.00
IQST cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 9107351.00
IQST cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -3166385.00
IQST balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 690742.00
IQST balance_sheet (annual, 2024-12-31) — Minority Interest: 4682506.00
IQST income_statement (annual, 2024-12-31) — Minority Interests: -811531.00
IQST cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -2955121.00
IQST cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: -225000.00
IQST cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 200000.00
IQST cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 100000.00
IQST balance_sheet (annual, 2024-12-31) — Net Debt: 5542127.00
IQST income_statement (annual, 2024-12-31) — Net Income: -5991567.00
IQST income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -6619277.00
IQST income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -5180036.00
IQST income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -5991567.00
IQST income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -5991567.00
IQST cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -5180036.00
IQST income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -5180036.00
IQST income_statement (annual, 2024-12-31) — Net Interest Income: -2371016.00
IQST cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 5940966.00
IQST cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 5940966.00
IQST income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -2371016.00
IQST cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -56230.00
IQST balance_sheet (annual, 2024-12-31) — Net PPE: 561802.00
IQST cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -151620.00
IQST cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 4831214.00
IQST balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -6970942.00
IQST balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 243108.00
IQST balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 243108.00
IQST income_statement (annual, 2024-12-31) — Normalized EBITDA: -249924.00
IQST income_statement (annual, 2024-12-31) — Normalized Income: -4508640.62
IQST cash_flow (annual, 2024-12-31) — Operating Cash Flow: -2930306.00
IQST cash_flow (annual, 2024-12-31) — Operating Gains Losses: 1875131.00
IQST cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: 681145.00
IQST income_statement (annual, 2024-12-31) — Operating Income: -620482.00
IQST income_statement (annual, 2024-12-31) — Operating Revenue: 283220442.00
IQST balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 2581102.00
IQST balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 5040558.00
IQST balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 1129582.00
IQST balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 1129582.00
IQST balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -25340.00
IQST income_statement (annual, 2024-12-31) — Other Gand A: 3498418.00
IQST income_statement (annual, 2024-12-31) — Other Income Expense: -1794508.00
IQST balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 7438654.00
IQST cash_flow (annual, 2024-12-31) — Other Non Cash Items: 1096725.00
IQST balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 999083.00
IQST income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 82614.00
IQST balance_sheet (annual, 2024-12-31) — Other Payable: 508804.00
IQST balance_sheet (quarterly, 2024-12-31) — Other Payable: 508804.00
IQST balance_sheet (annual, 2024-12-31) — Other Properties: 865352.00
IQST balance_sheet (annual, 2024-12-31) — Other Receivables: 115685.00
IQST income_statement (annual, 2024-12-31) — Other Special Charges: 482085.00
IQST income_statement (quarterly, 2024-12-31) — Other Special Charges: 351888.00
IQST balance_sheet (annual, 2024-12-31) — Payables: 2664658.00
IQST balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 3711720.00
IQST balance_sheet (annual, 2024-12-31) — Preferred Stock: 46.00
IQST income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 627710.00
IQST balance_sheet (annual, 2024-12-31) — Preferred Stock Equity: 46.00
IQST balance_sheet (annual, 2024-12-31) — Prepaid Assets: 2525991.00
IQST income_statement (annual, 2024-12-31) — Pretax Income: -4786006.00
IQST cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 1100000.00
IQST cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 425000.00
IQST cash_flow (annual, 2024-12-31) — Purchase Of Business: -2955121.00
IQST cash_flow (quarterly, 2024-12-31) — Purchase Of Business: -225000.00
IQST cash_flow (annual, 2024-12-31) — Purchase Of PPE: -151620.00
IQST balance_sheet (annual, 2024-12-31) — Receivables: 57948040.00
IQST income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 274948693.00
IQST income_statement (annual, 2024-12-31) — Reconciled Depreciation: 499535.00
IQST cash_flow (annual, 2024-12-31) — Repayment Of Debt: -3166385.00
IQST balance_sheet (annual, 2024-12-31) — Retained Earnings: -32703410.00
IQST income_statement (annual, 2024-12-31) — Salaries And Wages: 3186933.00
IQST income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 1643811.00
IQST income_statement (annual, 2024-12-31) — Selling General And Administration: 8392696.00
IQST balance_sheet (annual, 2024-12-31) — Share Issued: 2581102.00
IQST cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 5612499.00
IQST cash_flow (annual, 2024-12-31) — Short Term Debt Payments: -781285.00
IQST income_statement (annual, 2024-12-31) — Special Income Charges: -484076.00
IQST cash_flow (annual, 2024-12-31) — Stock Based Compensation: 223219.00
IQST balance_sheet (annual, 2024-12-31) — Stockholders Equity: 7217757.00
IQST balance_sheet (annual, 2024-12-31) — Tangible Book Value: -6970988.00
IQST income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -394195.62
IQST income_statement (annual, 2024-12-31) — Tax Provision: 394030.00
IQST income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
IQST balance_sheet (annual, 2024-12-31) — Taxes Receivable: 42673.00
IQST balance_sheet (annual, 2024-12-31) — Total Assets: 79007738.00
IQST balance_sheet (annual, 2024-12-31) — Total Capitalization: 10229683.00
IQST balance_sheet (annual, 2024-12-31) — Total Debt: 8052484.00
IQST balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 11900263.00
IQST income_statement (annual, 2024-12-31) — Total Expenses: 283840924.00
IQST balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 67107475.00
IQST balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 15992692.00
IQST balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 3286279.00
IQST income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -834064.00
IQST income_statement (annual, 2024-12-31) — Total Other Finance Cost: 211591.00
IQST income_statement (annual, 2024-12-31) — Total Unusual Items: -1877122.00
IQST income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -1877122.00
IQST balance_sheet (annual, 2024-12-31) — Working Capital: -806150.00
IQST income_statement (annual, 2024-12-31) — Write Off: 1991.00
IQST income_statement (quarterly, 2025-03-31) — +Operating Expense: 2517743.00
IQST income_statement (quarterly, 2025-03-31) — +Total Revenue: 57632816.00
IQST balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 8840686.00
IQST balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 21964399.00
IQST balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -1000974.00
IQST balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 40812472.00
IQST cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 0.00
IQST income_statement (quarterly, 2025-03-31) — Basic Average Shares: 2629867.00
IQST income_statement (quarterly, 2025-03-31) — Basic EPS: -0.44
IQST cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 2510357.00
IQST cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -49183.00
IQST balance_sheet (quarterly, 2025-03-31) — Capital Stock: 2684.00
IQST balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1085046.00
IQST balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1085046.00
IQST balance_sheet (quarterly, 2025-03-31) — Cash Financial: 1085046.00
IQST cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 540304.00
IQST cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -58645.00
IQST cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -1906969.00
IQST cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 690057.00
IQST cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -46331507.00
IQST cash_flow (quarterly, 2025-03-31) — Change In Inventory: 0.00
IQST cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 0.00
IQST cash_flow (quarterly, 2025-03-31) — Change In Payable: 690057.00
IQST cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -45641450.00
IQST cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -1391098.00
IQST cash_flow (quarterly, 2025-03-31) — Change In Receivables: 45924000.00
IQST cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -1108548.00
IQST cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 45924000.00
IQST cash_flow (quarterly, 2025-03-31) — Changes In Cash: -1425310.00
IQST balance_sheet (quarterly, 2025-03-31) — Common Stock: 2638.00
IQST balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 6859757.00
IQST income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 55697858.00
IQST balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 12378975.00
IQST balance_sheet (quarterly, 2025-03-31) — Current Assets: 26043799.00
IQST balance_sheet (quarterly, 2025-03-31) — Current Debt: 9033367.00
IQST balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 9033367.00
IQST balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 30279641.00
IQST cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 126995.00
IQST income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 126995.00
IQST cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 126995.00
IQST income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 126995.00
IQST income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 2629867.00
IQST income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.44
IQST income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -1157958.00
IQST balance_sheet (quarterly, 2025-03-31) — Duefrom Related Parties Current: 638177.00
IQST balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Current: 26613.00
IQST income_statement (quarterly, 2025-03-31) — EBIT: -592160.00
IQST income_statement (quarterly, 2025-03-31) — EBITDA: -465165.00
IQST balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 184918.00
IQST cash_flow (quarterly, 2025-03-31) — End Cash Position: 1085047.00
IQST cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 540304.00
IQST cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -1956152.00
IQST balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -25340.00
IQST income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 2171868.00
IQST balance_sheet (quarterly, 2025-03-31) — Goodwill: 6750045.00
IQST balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 14068386.00
IQST balance_sheet (quarterly, 2025-03-31) — Gross PPE: 1605277.00
IQST income_statement (quarterly, 2025-03-31) — Gross Profit: 1934958.00
IQST cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 109870.00
IQST income_statement (quarterly, 2025-03-31) — Insurance And Claims: 903.00
IQST income_statement (quarterly, 2025-03-31) — Interest Expense: 531726.00
IQST income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 531726.00
IQST cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 280415.00
IQST balance_sheet (quarterly, 2025-03-31) — Inventory: 30658.00
IQST balance_sheet (quarterly, 2025-03-31) — Invested Capital: 15893124.00
IQST cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -58645.00
IQST cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 1482500.00
IQST cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 987500.00
IQST cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -242687.00
IQST balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 737001.00
IQST balance_sheet (quarterly, 2025-03-31) — Minority Interest: 4696003.00
IQST income_statement (quarterly, 2025-03-31) — Minority Interests: -13497.00
IQST cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
IQST balance_sheet (quarterly, 2025-03-31) — Net Debt: 7948321.00
IQST income_statement (quarterly, 2025-03-31) — Net Income: -1157958.00
IQST income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -1157958.00
IQST income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -1144461.00
IQST income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -1157958.00
IQST income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -1157958.00
IQST cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -1144461.00
IQST income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -1144461.00
IQST income_statement (quarterly, 2025-03-31) — Net Interest Income: -553167.00
IQST cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 608949.00
IQST cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 744813.00
IQST income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -553167.00
IQST cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -68645.00
IQST cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -9462.00
IQST balance_sheet (quarterly, 2025-03-31) — Net PPE: 604303.00
IQST cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -49183.00
IQST cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: -135864.00
IQST balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -7208583.00
IQST balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 243108.00
IQST balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 243108.00
IQST income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -465165.00
IQST income_statement (quarterly, 2025-03-31) — Normalized Income: -1157958.00
IQST cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -1906969.00
IQST income_statement (quarterly, 2025-03-31) — Operating Income: -582785.00
IQST income_statement (quarterly, 2025-03-31) — Operating Revenue: 57632816.00
IQST balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 2683258.00
IQST balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 9033367.00
IQST balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -25340.00
IQST income_statement (quarterly, 2025-03-31) — Other Gand A: 1182991.00
IQST income_statement (quarterly, 2025-03-31) — Other Income Expense: 12066.00
IQST balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 7318341.00
IQST cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 186230.00
IQST balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 1060769.00
IQST income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 12066.00
IQST balance_sheet (quarterly, 2025-03-31) — Other Properties: 868276.00
IQST balance_sheet (quarterly, 2025-03-31) — Other Receivables: 98069.00
IQST balance_sheet (quarterly, 2025-03-31) — Payables: 8867299.00
IQST balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 21246274.00
IQST balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 46.00
IQST balance_sheet (quarterly, 2025-03-31) — Preferred Stock Equity: 46.00
IQST balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 2186635.00
IQST income_statement (quarterly, 2025-03-31) — Pretax Income: -1123886.00
IQST cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 0.00
IQST cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -49183.00
IQST balance_sheet (quarterly, 2025-03-31) — Receivables: 22741460.00
IQST income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 55697858.00
IQST income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 126995.00
IQST cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -873551.00
IQST balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -33930013.00
IQST income_statement (quarterly, 2025-03-31) — Salaries And Wages: 987974.00
IQST income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 218880.00
IQST income_statement (quarterly, 2025-03-31) — Selling General And Administration: 2390748.00
IQST balance_sheet (quarterly, 2025-03-31) — Share Issued: 2683258.00
IQST cash_flow (quarterly, 2025-03-31) — Short Term Debt Issuance: 495000.00
IQST cash_flow (quarterly, 2025-03-31) — Short Term Debt Payments: -630864.00
IQST income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
IQST cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 32815.00
IQST balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 6859803.00
IQST balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -7208629.00
IQST income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
IQST income_statement (quarterly, 2025-03-31) — Tax Provision: 20575.00
IQST income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
IQST balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 40815.00
IQST balance_sheet (quarterly, 2025-03-31) — Total Assets: 42020365.00
IQST balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 6859803.00
IQST balance_sheet (quarterly, 2025-03-31) — Total Debt: 9033367.00
IQST balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 11555806.00
IQST income_statement (quarterly, 2025-03-31) — Total Expenses: 58215601.00
IQST balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 30464559.00
IQST balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 15976566.00
IQST balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 184918.00
IQST income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -604226.00
IQST income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 21441.00
IQST income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
IQST income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
IQST balance_sheet (quarterly, 2025-03-31) — Working Capital: -4235842.00
IQST income_statement (quarterly, 2025-03-31) — Write Off: 0.00
IQST income_statement (quarterly, 2025-06-30) — +Operating Expense: 2513892.00
IQST income_statement (quarterly, 2025-06-30) — +Total Revenue: 72183236.00
IQST balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 9353772.00
IQST balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 30627972.00
IQST balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -1041890.00
IQST balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 45961191.00
IQST cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 4442.00
IQST income_statement (quarterly, 2025-06-30) — Basic Average Shares: 3003990.00
IQST income_statement (quarterly, 2025-06-30) — Basic EPS: -0.81
IQST cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1085047.00
IQST cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -46006.00
IQST balance_sheet (quarterly, 2025-06-30) — Capital Stock: 3557.00
IQST balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 2038288.00
IQST balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 2038288.00
IQST balance_sheet (quarterly, 2025-06-30) — Cash Financial: 2038288.00
IQST cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 810722.00
IQST cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -115167.00
IQST cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 257686.00
IQST cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 895670.00
IQST cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 15868573.00
IQST cash_flow (quarterly, 2025-06-30) — Change In Inventory: 0.00
IQST cash_flow (quarterly, 2025-06-30) — Change In Payable: 895670.00
IQST cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 16764243.00
IQST cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -3161477.00
IQST cash_flow (quarterly, 2025-06-30) — Change In Receivables: -12437397.00
IQST cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 1165369.00
IQST cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -12437397.00
IQST cash_flow (quarterly, 2025-06-30) — Changes In Cash: 953241.00
IQST balance_sheet (quarterly, 2025-06-30) — Common Stock: 3505.00
IQST balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 9533881.00
IQST income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 70311749.00
IQST balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 20572944.00
IQST balance_sheet (quarterly, 2025-06-30) — Current Assets: 35555030.00
IQST balance_sheet (quarterly, 2025-06-30) — Current Debt: 6890555.00
IQST balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 6890555.00
IQST balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 36843884.00
IQST cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 161229.00
IQST income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 161229.00
IQST cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 161229.00
IQST income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 161229.00
IQST income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 3003990.00
IQST income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.81
IQST income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -2406978.00
IQST balance_sheet (quarterly, 2025-06-30) — Duefrom Related Parties Current: 659338.00
IQST balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Current: 26613.00
IQST income_statement (quarterly, 2025-06-30) — EBIT: -1798100.00
IQST income_statement (quarterly, 2025-06-30) — EBITDA: -1636871.00
IQST balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 276614.00
IQST cash_flow (quarterly, 2025-06-30) — End Cash Position: 2038288.00
IQST cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 810722.00
IQST cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 211680.00
IQST balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -25340.00
IQST income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 1934276.00
IQST balance_sheet (quarterly, 2025-06-30) — Goodwill: 6750045.00
IQST balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 13948073.00
IQST balance_sheet (quarterly, 2025-06-30) — Gross PPE: 1651283.00
IQST income_statement (quarterly, 2025-06-30) — Gross Profit: 1871487.00
IQST cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 0.00
IQST income_statement (quarterly, 2025-06-30) — Insurance And Claims: 903.00
IQST income_statement (quarterly, 2025-06-30) — Interest Expense: 459118.00
IQST income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 459118.00
IQST cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 106124.00
IQST balance_sheet (quarterly, 2025-06-30) — Inventory: 30658.00
IQST balance_sheet (quarterly, 2025-06-30) — Invested Capital: 16424436.00
IQST cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -115167.00
IQST cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 2720000.00
IQST cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 3215000.00
IQST cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -1226872.00
IQST balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 784425.00
IQST balance_sheet (quarterly, 2025-06-30) — Minority Interest: 4754067.00
IQST income_statement (quarterly, 2025-06-30) — Minority Interests: -58064.00
IQST cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -50000.00
IQST balance_sheet (quarterly, 2025-06-30) — Net Debt: 4852267.00
IQST income_statement (quarterly, 2025-06-30) — Net Income: -2406978.00
IQST income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -2406978.00
IQST income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -2348914.00
IQST income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -2406978.00
IQST income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -2406978.00
IQST cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -2348914.00
IQST income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -2348914.00
IQST income_statement (quarterly, 2025-06-30) — Net Interest Income: -472942.00
IQST cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 879206.00
IQST cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 1988128.00
IQST income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -472942.00
IQST cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -68484.00
IQST cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -19161.00
IQST balance_sheet (quarterly, 2025-06-30) — Net PPE: 609393.00
IQST cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -46006.00
IQST cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: -1108922.00
IQST balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -4414140.00
IQST balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 243108.00
IQST balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 243108.00
IQST income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -541298.00
IQST income_statement (quarterly, 2025-06-30) — Normalized Income: -1541475.33
IQST cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 257686.00
IQST income_statement (quarterly, 2025-06-30) — Operating Income: -642405.00
IQST income_statement (quarterly, 2025-06-30) — Operating Revenue: 72183236.00
IQST balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 3565081.00
IQST balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 6890555.00
IQST balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -25340.00